BENCHMARK HOLDINGS PLC Benchmark Holdings , the aquaculture biotechnology company is pleased to announce that the MRL (Maximum Residue Limit) for Ectosan Vet has been adopted into the Agreement of the European Economic Area (the EEA Agreement); and today, has entered into Norwegian legislation completing the regulatory steps required for the commercialisation of Ectosan Vet and CleanTreat inNorway .Trond Williksen , CEO, commented: "With the granting of the Marketing Authorisation on 2nd July, the MRL ratified by theEuropean Commission and now in Norwegian legislation we have completed the regulatory steps required to begin the commercialisation of Ectosan Vet and CleanTreat inNorway ." "We are excited to bring this much needed solution to the salmon industry, driving sustainability through improved animal welfare and yield while protecting the environment." EnquiriesBenchmark Holdings plc Tel: 020 3696 0630Trond Williksen , CEOSeptima Maguire , CFOIvonne Cantu , Investor Relations Director Numis (Broker and NOMAD) Tel: 020 7260 1000James Black /Freddie Barnfield /Duncan Monteith MHPKatie Hunt /Alistair de Kare-Silver /Charlie Protheroe Tel: 020 3128 8742 benchmark@mhpc.com
Click here for more information
© Oslo Bors ASA, source
